Anke van Erp
0000-0002-8694-922X
Radboudumc
6 papers found
Refreshing results…
Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo
Targeted Therapy–based Combination Treatment in Rhabdomyosarcoma
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependent
Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
Genetic diversity of lactase persistence in East African populations
Missing publications? Search for publications with a matching author name.